Andrey J. Zarur, Ph.D. | Co-Founder, CEO & Chairman of the Board

Andrey J. Zarur, Ph.D. | Co-Founder, CEO & Chairman of the Board

Dr. Zarur is Co-Founder, Chairman & CEO of GreenLight Biosciences. Dr. Zarur has been active in early stage life sciences companies for over 20 years, and has actively participated in the creation of over a dozen companies in the healthcare and clean energy sectors. He is also a partner at Kodiak Venture Partners, a venture capital firm specializing in the formation of early stage information and life technology investments. Prior to joining Kodiak Venture Partners, he was founder and CEO of BioProcessors (now part of Agilent Technologies). In addition to BioProcessors, he has led four life science companies from inception to exit. He is also a co-founder and chairman of the board for Lumicell, and chairman of the board for Allegro Diagnostics. Dr. Zarur was named a Young Global Leader of the World Economic Forum in 2005, and he is an Overseer of the Museum of Science in Boston and a Senior Lecturer at MIT Sloan School of Management. Dr. Zarur holds Masters of Science degrees and a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology, and undergraduate degrees from the National University of Mexico. Dr. Zarur is the author of several peer-reviewed articles and holds close to 100 provisional and issued patents.

Marta Ortega-Valle, M.Sc., MBA  | Co-Founder, Vice President of Corporate Development

Marta Ortega-Valle, M.Sc., MBA  | Co-Founder, Vice President of Corporate Development

Mrs. Ortega-Valle is a Co-Founder of GreenLight and leads the company’s corporate development efforts, deploying collaboration agreements and taking products to commercialization with strategic partners in the chemical, pharmaceutical, consumer goods, and energy industries. Since the Company’s creation, Mrs. Ortega-Valle has successfully led multi-million collaboration agreements with life science companies from definition to execution. Prior to joining GreenLight, Mrs. Ortega-Valle was entrepreneur in residence at Kodiak Venture Partners where she started GreenLight with Dr. Zarur and Professor James Swartz.   Prior to that, Ms. Ortega-Valle was a senior manager at Accenture France, where she led the business intelligence group in Paris. As general manager of that group she was responsible for growth and business development, strategic partner relations, and large engagements management. Ortega-Valle has nine years of experience in business development and project management in global consulting engagement for companies in USA and Europe. Ortega-Valle holds a Master of Business Administration from Massachusetts Institute of Technology, Sloan Fellows Program at the Sloan School of Management, and a Master of Science in Electrical Engineering from ETSEIB (UPC) Engineering School of Barcelona.

Carole Cobb | Senior Vice President of Operations

Carole Cobb | Senior Vice President of Operations

Carole Cobb has over 25 years of experience in Biotechnology/ Fermentation-based Commercial Manufacturing, Process Development, Plant Operations and Supply Chain Management. Ms. Cobb was formerly the SVP, Global Supply, for Danisco A/S and Genencor International. During her tenure at Danisco/Genencor, Ms. Cobb successfully led the companies' biotechnology-based manufacturing strategy, growth and implementation, more than doubling the manufacturing infrastructure, including new plant construction and major capital expansions in Asia, South America and Europe, while increasing the output by more than 4X. Ms. Cobb oversaw ten manufacturing plants and 3 major warehouses worldwide. Ms. Cobb holds a M.B.A. in Finance and a B.S. in Chemical Engineering, Biochemistry and Cell and Molecular Biology.

Drew S. Cunningham, Ph.D. | Associate Director of Research

Drew S. Cunningham, Ph.D. | Associate Director of Research

Dr. Cunningham is the Associate Director of Research at GreenLight , where he leads teams focused on cell-free technology development and manages the metabolic engineering research efforts of multiple projects aimed at generating commercial products using GreenLight’s cell-free platform. Prior to joining GreenLight, Dr. Cunningham obtained a Doctor of Philosophy degree in Chemical Engineering from Carnegie Mellon University, where his doctoral efforts focused on producing DNA vaccines in bacterial hosts that were engineered using rational, model-predicted mutational strategies and synthetic biology. While attending Carnegie Mellon, Dr. Cunningham was an NIH Biotechnology Training Grant Fellow and received the Ken Meyer Graduate Research Award for research excellence. Dr. Cunningham also holds a Bachelor of Science degree in Chemical Engineering from the University of Pittsburgh, where he was the recipient of a Professional Promise Award by the American Institute of Chemical Engineers. Dr. Cunningham is an author of peer-reviewed publications in the fields of metabolic engineering, bacteriology, and biotechnology. In addition, he is an inventor on several provisional patents pertaining to cell-free bioprocessing and pathway engineering.